DENALI THERAPEUTICS INC (DNLI) Stock Cash Flow
NASDAQ:DNLI • US24823R1059
Current stock price
19.87 USD
+0.42 (+2.16%)
At close:
19.87 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -512.54M | -422.77M | -145.22M | -326.00M | -290.60M | |||
| Depreciation Amortization | 14.81M | 8.99M | 16.73M | 10.40M | 8.60M | |||
| Change In Working Capital | 149.00K | 16.94M | -289.93M | -24.00M | -23.40M | |||
| Interest Paid | 720.00K | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 46.00K | 0.00 | 3.00K | N/A | N/A | |||
| Other non cash items | 84.98M | 49.15M | 60.43M | 94.90M | 94.00M | |||
| OPERATING CASH FLOW | -412.60M | -347.69M | -357.99M | -244.70M | -211.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.50M | -15.91M | -12.94M | -17.80M | -8.50M | |||
| Other Investing Activity | 264.78M | -72.84M | 262.25M | -123.60M | -13.10M | |||
| INVESTING CASH FLOW | 255.28M | -88.76M | 249.31M | -141.40M | -21.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -8.17M | -32.34M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 197.71M | 516.64M | 17.82M | 310.70M | 19.30M | |||
| Other Financing Activity | -324.00K | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 189.22M | 484.30M | 17.82M | 310.70M | 19.30M | |||
| CHANGE IN CASH | 31.90M | 47.85M | -90.86M | -75.40M | -213.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -412.60M | -347.69M | -357.99M | -244.70M | -211.40M | |||
| Capital Expenditure | -9.50M | -15.91M | -12.94M | -17.80M | -8.50M | |||
| FREE CASH FLOW | -422.10M | -363.61M | -370.93M | -262.50M | -219.90M | |||
All data in USD